The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.

Rahway, New Jersey Friday, May 16, 2025, 13:00 Hrs [IST] ...

Welireg marks the first FDA-approved non-surgical treatment option for locally advanced, unresectable, or metastatic ...

Six years after Merck bought out Peloton Therapeutics, the New Jersey drugmaker is not remaining stationary with the crown ...

MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid ...

Rahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug ...

The Kinder Foundation has gifted $150 million to The University of Texas MD Anderson Cancer Center and Texas Children’s ...

A $150 million donation by the Kinder Foundation will fuel a new healthcare facility focused on combating childhood cancer as ...

The Kinder Foundation is donating $150 million to Texas Children's Hospital and the University of Texas MD Anderson Cancer ...

A new hospital is coming to the Texas Medical Center, thanks to one of the largest gifts in Houston healthcare history.

INDIANAPOLIS — No injuries were reported after a fire at the Community MD Anderson Cancer Center South on Friday afternoon. According to a social media post from the Indianapolis Fire Department, ...

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded a collaboration exploring medicines targeting lung cancer with KRAS mutations. The ...